Choosing Drug Therapy for Multiple Sclerosis: An Update

Author： van Oosten B.W.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.56, Iss.4, 1998-10, pp. : 555-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fingolimod for relapsing multiple sclerosis: an update

By Horga Alejandro   Castilló Joaquín   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1183-1196

Informa Healthcare

Access to resources Recommend Favorite

Treating multiple sclerosis with monoclonal antibodies: a 2013 update

By Deiß Annika   Brecht Isabel   Haarmann Axel   Buttmann Mathias  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 313-335

Informa Healthcare

Access to resources Recommend Favorite

An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis

By  

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 155-169

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Antioxidative Therapy of Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4720-4730

Bentham Science Publishers

Access to resources Recommend Favorite

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina   Kappos Ludwig   Sprenger Till  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite